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The aim of this work was to evaluate the effects of carnosol, a rosemary polyphenol, on pro-
inflammatory and catabolic mediators of cartilage breakdown in chondrocytes and via
bone-cartilage crosstalk.
Materials and Methods
Osteoarthritic (OA) human chondrocytes were cultured in alginate beads for 4 days in pres-
ence or absence of carnosol (6 nM to 9 μM). The production of aggrecan, matrix metallopro-
teinase (MMP)-3, tissue inhibitor of metalloproteinase (TIMP)-1, interleukin (IL)-6 and nitric
oxide (NO) and the expression of type II collagen and ADAMTS-4 and -5 were analyzed.
Human osteoblasts from sclerotic (SC) or non-sclerotic (NSC) subchondral bone were cul-
tured for 3 days in presence or absence of carnosol before co-culture with chondrocytes.
Chondrocyte gene expression was analyzed after 4 days of co-culture.
Results
In chondrocytes, type II collagen expression was significantly enhanced in the presence of
3 μM carnosol (p = 0.008). MMP-3, IL-6, NO production and ADAMTS-4 expression were
down-regulated in a concentration-dependent manner by carnosol (p<0.01). TIMP-1 produc-
tion was slightly increased at 3 μM (p = 0.02) and ADAMTS-5 expression was decreased
from 0.2 to 9 μM carnosol (p<0.05). IL-6 and PGE2 production was reduced in the presence
of carnosol in both SC and NSC osteoblasts while alkaline phosphatase activity was not
changed. In co-culture experiments preincubation of NSC and SC osteoblasts wih carnosol
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resulted in similar effects to incubation with anti-IL-6 antibody, namely a significant increase
in aggrecan and decrease in MMP-3, ADAMTS-4 and -5 gene expression by chondrocytes.
Conclusions
Carnosol showed potent inhibition of pro-inflammatory and catabolic mediators of cartilage
breakdown in chondrocytes. Inhibition of matrix degradation and enhancement of formation
was observed in chondrocytes cocultured with subchondral osteoblasts preincubated with
carnosol indicating a cross-talk between these two cellular compartments, potentially medi-
ated via inhibition of IL-6 in osteoblasts as similar results were obtained with anti-IL-6
antibody.
Introduction
The main feature of osteoarthritis (OA) is the progressive degradation and loss of the articular
cartilage accompanied by other critical structural changes, such as synovial membrane inflam-
mation, subchondral bone sclerosis, osteophytes formation at the joint margin, ligament laxity
and muscle atrophy [1]. All these structural changes contribute to symptoms of OA (severe
pain, stiffness, loss of joint mobility and disability).
Certain cytokines, such as IL-1β and TNF-α produced by activated synoviocytes, chondro-
cytes or monocytes, play a major role in the onset and the progression of OA [2]. These cyto-
kines stimulate their own production in a paracrine or autocrine manner and induce the
production of a wide range of other pro- inflammatory mediators, such as IL-6, IL-8, IL-17, IL-
18 and oncostatin M as well as reactive oxygen species such as nitric oxide, superoxide, hydro-
gen peroxide and peroxynitrite by joint cells [3]. These factors, together with inflammatory
prostaglandins (such as PGE2), leukotrienes and some adipokines, promote cartilage destruc-
tion by increasing the production and secretion of proteinases such as matrix metalloprotei-
nases (MMP) and aggrecanases [A Disintegrin and Metalloproteinase with Thrombospondin
Motifs (ADAMTS)-4 and -5)] [2].
Due to the presence of microcracks, vascular channels and neovascularization linking the
subchondral bone tissue and cartilage, it is hypothesized that cross-talk may occur between the
two tissues. Thus expression of proinflammatory mediators such as IL-6, TGF-β1 and probably
some other unexplored factors produced by subchondral osteoblasts could also contribute to
the abnormal remodelling of OA cartilage [4, 5].
We have previously demonstrated that osteoblasts isolated from subchondral OA bone
expressed an altered phenotype. More precisely, we demonstrated that osteoblasts coming
from the thickening (called sclerotic area, SC) of subchondral bone located just below a carti-
lage lesion exhibits an elevated alkaline phosphatase activity and express higher levels of IL-6,
IL-8, PGE2, TGF-β1 and type I collagen than osteoblasts coming from the non-thickening
neighbouring area (called non-sclerotic area, NSC) [5]. To investigate osteoblasts/chondrocytes
crosstalk, we developed an original co-culture model, in which human OA subchondral osteo-
blasts in monolayer are cultured with human OA chondrocytes in alginate beads. Using this
co-culture model, we have previously shown that SC osteoblasts, but not NSC osteoblasts,
induced a decrease of aggrecan and type II collagen mRNA levels and an increase of MMP-3
mRNA in chondrocytes [6, 7].
The aim of this study was to assess the chondroprotective effects of carnosol and related
mechanisms of action on cartilage breakdown in this co-culture model of chondrocytes and
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osteoblasts. Carnosol is an anti-inflammatory and anti-oxidant compound from rosemary.
Rosemary polyphenols, in particular carnosol and carnosic acid, are among the most potent
natural antioxidants, used in food preservation but also with health benefits such as anti-
inflammation and detoxification [8]. Carnosol was largely investigated for anti-tumoral, anti-
inflammatory and anti-oxidant activities in several cell line and animal models [9–12], but no
study was yet dedicated to its potential effect on joint cells and bone. Carnosol suppresses
inducible nitric oxide synthase down-regulating nuclear factor-B in mouse macrophages [13].
It suppresses cyclooxygenase (COX)-2 transcription in human mammary epithelial cells [14].
Carnosol also induces Nrf-2, an important transcriptional regulator of antioxidant, anti-
inflammatory and detoxification processes [15]. Furthermore, using neutralizing monoclonal
antibodies, we have highlighted the role played by mediators modified by carnosol in this oste-
oblast/chondrocyte crosstalk.
Materials and Methods
Origin of cells and ethics statement
OA human articular cartilage and subchondral bone was removed from knee joints patients
undergoing total knee-replacement surgery. All subjects provided written informed consent,
and ethical approval (ethics Committee of the University of Liège (reference number 2005/8)
was granted for this study.
Chondrocytes culture in alginate beads
OA cartilage was obtained from the knees of 7 men and 2 women aged from 52 to 76 years old,
being excised from the superficial and medium layers of cartilage and avoiding the calcified
layer, enzymatically digested and primary chondrocytes were cultured in alginate bead at a
density of 4 x 106 cells/ml in 1.2% low viscosity alginate (Sigma-Aldrich, Belgium) as previously
described [16]. Ten alginate beads containing OA chondrocytes were placed in porous inserts
(with 1 μm pore size; Falcon, BD Biosciences, Erembodegem, Belgium). The chondrocytes in
alginate beads were maintained two days in DMEM supplemented with 2% Ultroser G, 10 mM
HEPES, penicillin (100 U/ml) and streptomycin (100 μg/ml), to avoid contamination with
drugs that donors might have taken before death. After this wash out period, culture medium
was changed and the chondrocytes were either co-cultured with NSC or SC subchondral osteo-
blasts for 4 days (see next paragraph), or cultured alone (mono-culture) with carnosol (Cay-
man Chemical) from 6 nM to 9 μM for 4 days. The experiment on chondrocytes mono-
cultures were repeated three times, each time using cells coming from a different donor. Carno-
sol was first dissolved in DMSO and then diluted in incubation medium to the required final
concentration. The final concentration of DMSO was 0.02% in all culture conditions. The
nutrient media used was DMEM supplemented with 1% ITS+ (Lonza, Belgium), 10 mM
HEPES, 100 U/ml penicillin, 100 μg/ml streptomycin, 2mM glutamine (Lonza, Belgium),
50 μg/ml ascorbic acid (Sigma-Aldrich, Belgium), 20 μg/ml proline (Invitrogen, Belgium). ITS
+ is a premixed cell growth system containing in one ml: 0.625 mg insulin, 0.625 mg transfer-
rin, 0.625 μg selenious acid, 0.125 g bovine serum albumin and 0.535 mg linoleic acid.
Subchondral osteoarthritic osteoblasts in monolayer culture
Tibial subchondral bone plates were obtained from 9 OAmen (age ranged from 40 to 79 years).
After careful elimination of trabecular bone and articular cartilage, OA subchondral bone was
dissected to separate non sclerotic (NSC) from SC zones [5]. We have considered as SC bone
only the subchondral bone zones with a thickness greater than 2 mm and either denuded or
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overlaid by fibrillated cartilage. Also, we have considered as NSC bone only the subchondral
bone zones with a maximal thickness of 1 mm. Osteoblasts from SC or NSC subchondral bone
were then obtained by outgrowth from explants as previously described [5]. At confluence, pri-
mary cells were collected by trypsinization, seeded (50,000 cells/cm2) in 12-well plates (12-well
companion plates, Falcon, BD Biosciences, Erembodegem, Belgium) and grown for 3 days in
DMEM containing 10% FBS, 100 U/ml penicillin, 100 μg/ml streptomycin, 10 mMHEPES.
After washings, osteoblasts were maintained for 12 days in a differentiation media, composed of
DMEM containing 100 U/ml penicillin, 100 μg/ml streptomycin, 10 mMHEPES, 2% Ultroser
G, a serum substitute, 10−8 M 1,25(OH)2vitaminD3 (Sigma-Aldrich, Belgium), 2 mM glutamine,
50 μg/ml ascorbic acid and 20 μg/ml proline. At the end of this differentiation period, cells
expressed an osteoblastic phenotype characterized by the production of osteocalcin and alkaline
phosphatase [5]. After washings, cells were then cultured in ITS+ medium for 72 hours in the
absence or in the presence of carnosol ranging from 6 nM to 9 μM. The experiment was
repeated three times, each time using subchondral osteoblasts coming from a different donor.
OA osteoblasts/chondrocytes co-culture
The inserts (with a pore size of 1 μm; Falcon, BD Biosciences, Belgium) containing ten alginate
beads were co-cultured for 4 days with osteoblasts in monolayer, as previously described [17].
Before co-culture, osteoblasts were pre-incubated or not with carnosol for 72h. Before co-cul-
ture, osteoblasts were extensively washed with PBS. Co-culture medium was DMEM supple-
mented with 1% ITS+, 10 mMHEPES, 100 U/ml penicillin, 100 μg/ml streptomycin, 2 mM
glutamine, 50 μg/ml ascorbic acid, 20 μg/ml proline. To identify the osteoblast-secreted media-
tors involved in chondrocyte responses, we have also tested piroxicam (7 μg/ml) or 5μg/ml of
Mab neutralizing the activity of human IL-6, or TGF-β1 and β3 (TGFβ1/β3) or HGF (R&D sys-
tems, UK) in co-culture and monoculture. Six wells of a 12-well plate were used for each cul-
ture conditions. The experiment was repeated three times, each time using subchondral
osteoblasts coming from a different donor. Conversely, the origin of OA chondrocytes was
from a distinct donor than osteoblasts. As controls, OA chondrocytes in alginate beads were
cultured alone (mono-culture). The cell pellets of chondrocytes were homogenized in 1 ml PBS
by ultrasonic dissociation for DNA and aggrecan quantification or in 600 μl of cell lysis buffer
(Qiagen) for RNA isolation. Cell extracts were kept at -80°C until analysis.
DNA assay
The DNA content of the cell cultures was measured according to the fluorimetric method of
Labarca and Paigen [18].
LDH release assay
The cell viability was estimated by the ratio of lactate deshydrogenase (LDH) released in the
culture supernatant, as previously described [16].
Immunoassays for aggrecan, IL-6, MMP-3, TIMP-1 and PGE2
IL-6 and MMP-3 were directly measured in chondrocytes or osteoblasts-conditioned culture
supernatant by specific EASIA (Enzyme Amplified Sensitivity ImmunoAssays, Invitrogen, Bel-
gium). Aggrecan was measured in the different compartments of alginate bead and in culture
supernatants by a specific EASIA (Invitrogen, Belgium). In the case of MMP-3, the antibodies
were directed against pro-MMP-3, activated-MMP-3 and MMP-3 bound to TIMP-1 and
TIMP-2. PGE2 was assayed according to a previously described radioimmunoassay [19].
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Alkaline phosphatase assay
Alkaline phosphatase activity was quantified in the cellular fraction of the osteoblasts culture,
using p-nitrophenylphosphate as substrate, as previously described [17]. Results were
expressed in nmoles of p-nitrophenol released per min and per μg of DNA.
Nitrite assay
Nitric oxide (NO) production was determined by quantifying its derived product, nitrite, in the
culture supernatant using a spectrophotometric method based upon the Griess reaction, as pre-
viously described [20]. Briefly, a sample of the supernatant or sodium nitrite (NaNO2) stan-
dard dilutions was mixed with Griess reagent (0.5% sulphanilamide, 0.05% naphtyl ethylene
diamine dihydrochloride, 2.5% H3PO4). The absorption was measured at 540 nm.
Quantitative Real-time RT PCR
RNA from 1.106 cells was isolated by RNeasy mini kit (Qiagen), reverse transcription made
with superscript III (Invitrogen) and polymerase chain reaction (PCR) was performed by using
the Light Cycler-FastStart DNAMaster Sybr Green I (LC480, Roche Diagnostics, Brussels, Bel-
gium). The PCR template source was either 3 ng first-strand cDNA or purified DNA standard.
Primer sequences used to amplify the desired cDNA were as shown in Table 1. Glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH), a house keeping gene, was used as internal con-
trol and gene expressions were normalised by calculating the expression of aggrecan, type II
collagen (COL2A1), MMP-3, ADAMTS-4, -5 and that of GAPDH.
Statistical analysis
The results (mean ± SD) were expressed as GAPDH-normalized gene expression or as the con-
centration per μg of DNA. A One-way Analysis of Variance (ANOVA) test followed by a
Tukey-Kramer Multiple Comparisons Post-test was performed on means of all the experi-
ments, and Pearson correlations were performed to compare concentration-dependence
(GraphPad Prism 6.0). Log(agonist) or log(inhibitor) vs response non linear fit was used to
estimate the IC50 (GraphPad Prism 6.0).
Results
Effect of carnosol on proliferation and viability of chondrocytes and
osteoblasts in culture
At concentrations ranging from 6 nM to 9 μM, no significant variation of chondrocyte or oste-
oblast viability, as evaluated by the LDH release, was observed in our cultures. The DNA con-
tent remained stable in our culture conditions.
Effect of carnosol on OA chondrocyte metabolism
After 4-days of culture, carnosol did not significantly modify the aggrecan production or gene
expression by chondrocytes, but significantly enhanced type II collagen gene expression at
3 μM (1.61-fold, p = 0.0008, Fig 1A). Carnosol also significantly reduced in a concentration-
dependent manner the ADAMTS-4 (IC50 = 8.5 μM, r = -0.9463, p = 0.0012, Fig 1B) and
ADAMTS-5 gene expression at 0.2 μM and higher concentrations (1.5-fold, p<0.05, Fig 1C).
Carnosol significantly decreased MMP-3 protein production in a concentration-dependent
manner (IC50 = ~9.6μM, r = -0.9684, p = 0.0003) and enhanced TIMP-1 protein production at
3 μM (1.24-fold, p = 0.02) by OA chondrocytes (Fig 2A and 2B). These effects were associated
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with a concentration-dependent decrease of the MMP3/TIMP-1 ratio (IC50 = 3μM, r =
-0.9770, p = 0.0002).
Finally, carnosol significantly down-regulated chondrocyte production of IL-6
(IC50 = 2.3 μM, r = -0.9067, p = 0.0049 Fig 2C) and NO (IC50 = 5.3 μM, r = -0.9942,
p<0.0001, Fig 2D) in a concentration-dependent manner. The inhibitory effect of carnosol on
these parameters was statistically significant at concentration of 1 μM and above.
Effect of carnosol on OA subchondral osteoblasts
Alkaline phosphatase activity was higher in SC osteoblasts than in NSC osteoblasts (10494 +/-
1833 vs 13254 +/- 1652 U/μg DNA, p = 0.006). Carnosol did not significantly affect the alkaline
phosphatase activity of NSC or SC osteoblasts (Fig 3A).
SC osteoblasts produced higher levels of IL-6 and PGE2 than NSC osteoblasts (1.6 and
3.1-fold, p<0.001), and NO production was below detection levels in both NSC and SC osteo-
blasts. Carnosol reduced IL-6 production in a concentration-dependent manner
(IC50 = 0.6 μM, r = -0.7674, p = 0.0440 in NSC and IC50 = 2.7μM, r = -0.7861, p = 0.0361 in
SC osteoblasts, 0.45-fold at 9 μM in NSC and 0.36-fold in SC, Fig 3B). At 9 μM, carnosol inhib-
ited PGE2 production in both NSC and SC cultures (0.19-fold in NSC and 0.39 fold in SC oste-
oblasts, p<0.01, Fig 3C).
Effect of carnosol on OA chondrocytes co-cultured with subchondral
osteoblasts
When chondrocytes were co-cultured with osteoblasts, NSC osteoblasts did not significantly
modify aggrecan protein production by chondrocytes, while SC osteoblasts significantly
reduced total aggrecan production by 15+/-4% (p = 0.043). Aggrecan gene expression by chon-
drocytes was decreased by 25+/-8% in co-culture with NSC osteoblasts (p = 0.032) and by 58
+/-7% with SC osteoblasts co-culture (p = 0.0053, Fig 4A). The pre-treatment of SC osteoblasts
with carnosol at 1 or 5 μM fully prevented the inhibition of aggrecan gene expression by chon-
drocytes and even enhanced this gene expression by 3.7 and 4.2-fold (p<0.05 and p<0.01, Fig
4A). Type II collagen gene expression was not significantly modified in presence of NSC osteo-
blasts, but was reduced by SC osteoblasts (0.55-fold, p = 0.0006, Fig 4B). Carnosol did not affect
the inhibitory effect of SC osteoblasts on COL2A1 gene expression (Fig 4B).
Table 1. Primers Sequences .
cDNA 5’-3’ bp
GAPDH Forward TTGGTATCGTGGAAGGACTCA 269
Reverse TGTCATCATATTTGGCAGGTTT
AGC Forward TCTACCTCTGCGGTAGGG 154
Reverse GGAAGTTCACTGACATCCTCTAT
COL2A1 Forward GGATGCCACACTCAAG 216
Reverse TTGGGGTAGACGCAAG
MMP-3 Forward CCCAAGAGGCATCCAC 264
Reverse GGGTCAAACTCCAACTGT
ADAMTS4 Forward AGAAGAAGTTTGACAAGTGC 225
Reverse GCGTGTATTCACCATTGAG
ADAMTS5 Forward ATCACCCAATGCCAAGG 246
Reverse AGCAGAGTAGGAGACAAC
doi:10.1371/journal.pone.0136118.t001
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Fig 1. Effect of Carnosol on Chondrocyte Gene Expression. (A) COL2A1, (B) ADAMTS-4, (C) ADAMTS-
5. Gene expression was normalized to GAPDH. The results are expressed as the mean ± SD of three
experiments performed with cells coming from three different donors. ANOVAwith Tukey posttest performed
between treated and untreated cells, * = p<0.05, ** = p<0.01 and *** = p<0.001.
doi:10.1371/journal.pone.0136118.g001
Carnosol In Vitro Chondroprotective Effects
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Fig 2. Effect of Carnosol on Chondrocyte Protein Production. (A) MMP-3, (B) TIMP-1, (C) IL-6 and (D)
NO. Production was normalized to DNA content. The results are expressed as the mean ± SD of three
experiments performed with cells coming from three different donors. ANOVAwith Tukey posttest performed
between treated and non-treated cells, * = p<0.05 and *** = p<0.001.
doi:10.1371/journal.pone.0136118.g002
Carnosol In Vitro Chondroprotective Effects
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When the chondrocytes were co-cultured with NSC osteoblasts, ADAMTS-4 and -5 expres-
sion by chondrocytes were 3-fold or 1.8-fold upregulated (p<0.001), but MMP-3 gene expres-
sion was unchanged. In co-culture with SC osteoblasts, ADAMTS-4 / -5 and MMP-3, mRNA
levels were 4.6-fold, 4.4-fold (p<0.001) and 1.3-fold (p<0.05), respectively, increased
Fig 3. Effect of Carnosol on Activity of Alkaline Phosphatase (A), Production of IL-6 (B) and PGE2 (C)
in NSC and SC Subchondral Osteoblasts. The results were normalized to the DNA content and are
expressed as the mean ± SD of three experiments performed with cells coming from three different donors.
ANOVA with Tukey posttest performed between treated and non-treated cells, ** = p<0.01 and *** =
p<0.001.
doi:10.1371/journal.pone.0136118.g003
Carnosol In Vitro Chondroprotective Effects
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Fig 4. Effect of Carnosol Pre-treatment of Subchondral Osteoblasts on Chondrocyte Gene Expression after 4 Days of Co-culture with Osteoblasts.
(A) AGC, (B) COL2A1, (C) MMP-3, (D) ADAMTS-4, (E) ADAMTS-5. Gene expression was normalized to GAPDH. The results are expressed as the
mean ± SD of three experiments performed with cells coming from three different donors, and presented as ratio of chondrocytes monoculture experiments
run in parallel. ANOVA with Tukey posttest statistical significances: Chondrocytes/osteoblasts co-culture compared to mono-culture * = p<0.05, ** = p<0.01,
*** = p < 0.001; SC osteoblasts compared to NSC osteoblasts # = p<0.05, ## = p<0.01, ### = p<0.001; SC osteoblasts in co-culture with inhibitors
compared to SC osteoblasts without inhibitors: ° = p<0.05, °° = p<0.01 and °°° = p<0.001.
doi:10.1371/journal.pone.0136118.g004
Carnosol In Vitro Chondroprotective Effects
PLOS ONE | DOI:10.1371/journal.pone.0136118 August 20, 2015 10 / 15
compared to chondrocytes in mono-culture. Pre-incubation of SC or NSC osteoblasts with car-
nosol at 1 or 5 μg/ml induced a significant reduction of ADAMTS-4 / -5 and MMP-3 gene
expression by chondrocytes (SC: 0.3-fold, p<0.001, NSC: 0.5-fold, p<0.05, Fig 4C–4E).
Effects of subchondral sclerotic osteoblast mediators on chondrocyte
To identify the osteoblastic mediators triggering the chondrocytes responses, we incubated
subchondral osteoblast/chondrocyte co-cultures in the presence of monoclonal antibodies
(Mabs) neutralizing either IL-6 or TGF-β1 or HGF activity, or with piroxicam as PGE2 inhibi-
tor (Fig 5). The addition of the Mabs or piroxicam completely neutralized the expression of
these proinflammatory mediators as of IL-6, TGF-β1 or PGE2 by were non detectable in the
culture supernatants by specific ELISA tests. In comparison to chondrocyte mono-culture with
the same neutralizing agents, only anti-IL-6 Mab significantly inhibited the effect of SC osteo-
blasts on AGC (1.45-fold, p = 0.0009), COL2A1 (1.8-fold, p = 0.0312), MMP-3 (0.5-fold,
p = 0.0008), ADAMTS-4 (0.29-fold, p<0.0001) and -5 (0.29-fold, p<0.0001) gene expression
(Fig 5). The same range of effect was observed also on NSC osteoblasts (Fig 5). Piroxicam also
significantly decreased the MMP-3 expression (p = 0.03) in NSC osteoblasts co-culture.
Discussion
In this study, we have shown that in vitro, at similar ranges of concentrations to those bioavail-
able in tissues after rosemary extracts administration [21], carnosol is a good candidate as anti-
OA agent. On chondrocytes, carnosol has an interesting stimulating effect on type II collagen
gene expression and an inhibitory effect on MMP-3 production, and ADAMTS-4 and -5 gene
expression. Further, TIMP-1 synthesis was increased by carnosol suggesting that this product
can also down-regulate MMP activity. Carnosol showed also potent anti-inflammatory activi-
ties by decreasing NO and IL-6 synthesis.
In addition to these direct effects on chondrocyte metabolism, carnosol also exerts a protec-
tive effect on the deleterious activities of OA subchondral osteoblasts on chondrocytes,
observed in our co-culture model. Indeed, pre-treatment of OA sclerotic subchondral osteo-
blasts with carnosol mediated an increase in cartilage matrix formation components (aggrecan,
type II collagen) and decrease in gene expression of degradation enzymes (MMP-3, ADAMTS4
and -5) by chondrocytes.
As previously shown by ourselves [17, 22] and others [23, 24], OA subchondral osteoblasts,
in particular coming from sclerotic subchondral bone, can modify the gene expression of chon-
drocytes in co-culture, leading to a phenotype suitable for matrix degradation We therefore
tested the effect of carnosol on certain factors in OA subchondral osteoblasts which could be
responsible for mediating the protective effects of carnosol on matrix formation and degrada-
tion in cocultures. Carnosol did not modify alkaline phosphatase activity of the osteoblasts, but
did it reduce IL-6 production at 1 μM, and at 9 μM also PGE2 production. These effects of car-
nosol were observed in the same way either on NSC and SC osteoblasts.
Finally, we investigated the effects of cytokines and growth factors involved in bone remod-
elling for their potency to trigger the deleterious effects of SC osteoblasts on the overlying carti-
lage in OA. TGF-β1/3, IL-6 and PGE2 are regulators of bone remodelling and are involved in
subchondral bone sclerosis associated with OA. Moreover, they are overexpressed in OA scle-
rotic subchondral bone [5, 25, 26]. Further, HGF, a factor produced by subchondral osteo-
blasts, but not by chondrocytes, was found in the deep layer of the cartilage indicating that
factors produced by bone cells can cross over the osteochondral bone plate [27]. In our co-cul-
ture model, we tested the effects of neutralizing factors to each of these mediators, and among
them only IL-6 seems to be involved. To the best of our knowledge, this is the first time that IL-
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Fig 5. Effect of IL-6 Neutralizing Mab on Gene Expression by Chondrocytes. (A) AGC, (B) COL2A1, (C) MMP-3, (D) ADAMTS-4 and (E) -5 gene
expressions by chondrocytes after four days of culture in the absence (mono-culture) or in the presence (co-culture) of osteoblasts isolated from sclerotic
(SC) or non-sclerotic (NSC) zones of subchondral bone. The culture was performed in absence or in the presence of 5 μg/ml of anti-IL-6, TGF-β1/3 or HGF
Mab or 7 μg/ml of piroxicam (Pirox). GAPDH-normalized gene expressions are reported to mono-culture expression level, and represented as the mean ± SD
of three experiments performed with cells coming from three different donors. Comparison of mean values of gene expression was performed by Mann-
Carnosol In Vitro Chondroprotective Effects
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6 is identified as a key mediator of the cross talk between subchondral bone and cartilage in
OA.
We observed that the inhibitory effect of SC osteoblasts on the production of aggrecan by
chondrocytes was abolished by neutralizing the biological activity of IL-6. In addition, type II
collagen gene expression inhibition by osteoblasts was reversed by about 50% in the presence
of anti-IL-6. Neutralization of IL-6 also abolished the effect of SC osteoblasts on the expression
of MMP-3, ADAMTS-4 and -5 by chondrocytes. Previously, Sanchez et al. [28] demonstrated
that IL-6 in the presence of its soluble receptor, stimulated the production of MMP-3 and
inhibited the synthesis of aggrecan by chondrocytes in alginate beads. Other authors have
shown that IL-6 inhibited the expression of type II collagen and the aggrecan link protein by
bovine chondrocytes cultured in monolayer, in parallel with an inhibition of the expression of
the transcription factor sox9 [29]. IL-6 acts in synergy with IL-1 in vitro to degrade collagens
and proteoglycans in cartilage explants [30]. These results emphasize the key role played by IL-
6 in cartilage degradation. They also emphasize the important role of this cytokine in the cross-
talk between subchondral bone and cartilage. Furthermore, these results are consistant with
previous results showing that pre-treatment of NSC osteoblasts with IL-6 led to the same dele-
terious effect than untreated SC osteoblasts on chondrocytes in co-culture [17]. Finally, these
data indicate that the protective effects of carnosol against osteoblast-induced deregulation of
chondrocyte metabolism is probably mediated by IL-6.
While we cannot exclude the involvement of other factors, our study clearly demonstrates
that PGE2 TGF-β1–3 and HGF are not involved in the cross-talk between osteoblasts and
chondrocytes, and identifies IL-6 as a key factor of the osteoblasts/chondrocytes crosstalk in
OA.
Conclusion
Carnosol showed potent anti-inflammatory and anti-catabolic effects on chondrocytes. Fur-
thermore, it was able to reduce cartilage matrix breakdown and enhance its formation in pres-
ence of subchondral osteoblasts, probably by inhibition of IL-6 production by osteoblasts. Its
effects would deserve to be further confirmed and investigated, in an appropriate animal model
and then in clinical studies.
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